CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 75  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.1259
LYS 10.0424
GLU 20.0278
LEU 30.0266
ARG 40.0254
CYS 50.0252
GLN 60.0214
CYS 70.0174
ILE 80.0366
LYS 90.0754
THR 100.0252
TYR 110.0112
SER 120.0128
LYS 130.0165
PRO 140.0170
PHE 150.0073
HIS 160.0075
PRO 170.0066
LYS 180.0111
PHE 190.0094
ILE 200.0087
LYS 210.0349
GLU 220.0267
LEU 230.0168
ARG 240.0285
VAL 250.0317
ILE 260.0342
GLU 270.0361
SER 280.0274
GLY 290.0367
PRO 300.1259
HIS 310.0370
CYS 320.0295
ALA 330.0705
ASN 340.0383
THR 350.0199
GLU 360.0228
ILE 370.0140
ILE 380.0179
VAL 390.0068
LYS 400.0066
LEU 410.0074
SER 420.0167
ASP 430.0289
GLY 440.0128
ARG 450.0133
GLU 460.0132
LEU 470.0100
CYS 480.0185
LEU 490.0093
ASP 500.0132
PRO 510.0119
LYS 520.0124
GLU 530.0148
ASN 540.0106
TRP 550.0043
VAL 560.0065
GLN 570.0091
ARG 580.0107
VAL 590.0040
VAL 600.0039
GLU 610.0073
LYS 620.0022
PHE 630.0040
LEU 640.0152
LYS 650.0103
ARG 660.0060
ALA 670.0162
GLU 680.0199
ASN 690.0122

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.